© Copyright 2016 The KINDReD ASSOCIATION. All rights reserved.
Made in France
PIPELINE
Currently, The KINDReD Association owns two promising therapeutic molecules validated by preclinical
studies.
Candicidin, a promising therapeutic molecule designed to fight
against cutaneous Leishmaniasis.
More information available soon.
K777, a promising therapeutic molecule designed to defeat Chagas
disease.
More information available soon.
Together, we will win against
neglected infectious diseases.
© Copyright 2016 The KINDReD ASSOCIATION. All rights
reserved.
Made in France
PIPELINE
Currently, The KINDReD
Association owns two
promising therapeutic
molecules validated by
preclinical studies.
Candicidin, a
promising therapeutic
molecule designed to
fight against
cutaneous
Leishmaniasis.
More information available soon.
K777, a promising
therapeutic molecule
designed to defeat
Chagas disease.
More information available soon.
Together, we will win against
neglected infectious diseases.
HOME
MEMBERS
NEGLECTED PARASITIC DISEASES
DRUG DEVELOPMENT
PIPELINE
NEWS & PUBLICATIONS
JOIN US
CONTACT